This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Juno Therapeutics Inc.

Drug Names(s): ROR-1 chimeric antigen receptor T-cell therapy, ROR-1 CAR-T Therapy, JCAR-024

Description: Juno is developing a compound using chimeric antigen receptor (CAR) modified T cells targeted towards ROR-1 expressed tumors.

JCAR024 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug